Susan K. Logan

Affiliations: 
Basic Medical Science New York University, New York, NY, United States 
Area:
Pharmacology, Molecular Biology, Microbiology Biology
Google:
"Susan Logan"

Children

Sign in to add trainee
Paolo Mita grad student 2012 NYU
Julia A. Staverosky grad student 2012 NYU
Paolo Mita grad student 2006-2012 NYU Langone Medical Center
Eugine Lee grad student 2014 NYU
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang Y, Schafler ED, Thomas PA, et al. (2019) Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 10: 707-716
Thomas PA, Mita P, Ha S, et al. (2018) Role of the Unconventional Prefoldin Proteins URI and UXT in Transcription Regulation. Advances in Experimental Medicine and Biology. 1106: 85-94
Schneider JA, Craven TW, Kasper AC, et al. (2018) Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Nature Communications. 9: 4396
Schafler ED, Thomas PA, Ha S, et al. (2018) UXT is required for spermatogenesis in mice. Plos One. 13: e0195747
Briggs EM, Ha S, Mita P, et al. (2018) Long interspersed nuclear element-1 expression and retrotransposition in prostate cancer cells. Mobile Dna. 9: 1
Mita P, Savas JN, Briggs EM, et al. (2016) URI Regulates KAP1 Phosphorylation and Transcriptional Repression Via PP2A Phosphatase in Prostate Cancer Cells. The Journal of Biological Chemistry
Wang Y, Dehigaspitiya DC, Levine PM, et al. (2016) Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation. Cancer Research
Wang Y, Ledet RJ, Imberg-Kazdan K, et al. (2016) Dynein axonemal heavy chain 8 promotes androgen receptor activity and associates with prostate cancer progression. Oncotarget
Lee E, Ha S, Logan SK. (2015) Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. Plos One. 10: e0141589
Daniels G, Li Y, Gellert LL, et al. (2014) TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth. Endocrine-Related Cancer. 21: 127-42
See more...